| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |